345 related articles for article (PubMed ID: 18451255)
21. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.
Wu CY; Chen JT; Chen GH; Yeh HZ
Hepatogastroenterology; 2002; 49(47):1465-8. PubMed ID: 12239968
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
23. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
[TBL] [Abstract][Full Text] [Related]
26. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
27. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer.
Röcken C; Röhl FW; Diebler E; Lendeckel U; Pross M; Carl-McGrath S; Ebert MP
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1206-12. PubMed ID: 17548686
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT
Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416
[TBL] [Abstract][Full Text] [Related]
29. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
[TBL] [Abstract][Full Text] [Related]
31. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
32. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese.
Xu E; Lai M; Lŭ B; Xing X; Huang Q
Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230
[TBL] [Abstract][Full Text] [Related]
33. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth.
Kawano K; Yanagisawa S
Head Neck; 2006 Jun; 28(6):525-33. PubMed ID: 16619276
[TBL] [Abstract][Full Text] [Related]
35. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
36. Effect of a matrix metalloproteinase inhibitor on a lymph node metastatic model of gastric cancer cells passaged by orthotopic implantation.
Matsuoka T; Yashiro M; Sawada T; Ishikawa T; Ohira M; Hirakawa K; Chung YS
J Exp Clin Cancer Res; 2001 Jun; 20(2):213-8. PubMed ID: 11484977
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
[TBL] [Abstract][Full Text] [Related]
38. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
40. [Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer].
Koumura H; Sugiyama Y; Kunieda K; Saji S
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():324-31. PubMed ID: 9263524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
